A common blood test may miss ovarian cancer in some Black and Native American patients, delaying their treatment, a new study ...
A new study finds that a common blood test for ovarian cancer may miss some Black and Native American patients, delaying ...
The measurement of serum CA-125 antigen is a standard procedure in the management of patients with advanced ovarian cancer. A study by Markman et al. showed that decreased concentration of serum ...
The cancer antigen (CA)-125 test may miss ovarian cancer in some Black and Native American patients, delaying their treatment ...
The new study, supported by grants from the National Cancer Institute and published Thursday in JAMA Network Open, looked at a test called CA-125. The test measures a tumor marker in the blood ...
This could lead to delays in treatment and poorer health outcomes. The study, published in JAMA Network Open, looked at more than 200,000 women with ovarian cancer who took a test called CA-125. This ...
A significant study detailing OncoSeek®'s efficacy was published in eClinicalMedicine, a clinical journal of The Lancet, titled A panel o ...